Yang Ke

962 total citations
34 papers, 617 citations indexed

About

Yang Ke is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Yang Ke has authored 34 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Hepatology. Recurrent topics in Yang Ke's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Nanoparticle-Based Drug Delivery (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yang Ke is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Nanoparticle-Based Drug Delivery (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yang Ke collaborates with scholars based in China, India and Taiwan. Yang Ke's co-authors include Lin Wang, Le‐Qun Li, Jian‐Hong Zhong, Haoran Tang, Yanyan Wang, Tianhao Bao, Cheng Zhang, Xuesong Wu, Yan Wang and Kui Xiang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Cancer and International Journal of Pharmaceutics.

In The Last Decade

Yang Ke

33 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Ke China 14 250 159 126 112 84 34 617
Chung-Kwe Wang Taiwan 12 222 0.9× 219 1.4× 93 0.7× 129 1.2× 84 1.0× 12 617
Maria Rita Emma Italy 18 456 1.8× 76 0.5× 152 1.2× 123 1.1× 69 0.8× 25 846
Xiong Cai China 13 222 0.9× 154 1.0× 77 0.6× 202 1.8× 95 1.1× 31 657
Huibin Lu China 11 287 1.1× 55 0.3× 196 1.6× 45 0.4× 79 0.9× 26 573
Yajing Yang China 15 347 1.4× 137 0.9× 73 0.6× 32 0.3× 38 0.5× 26 789
Weiya Cao China 13 355 1.4× 42 0.3× 112 0.9× 215 1.9× 26 0.3× 27 696
Hongyao Liu China 11 191 0.8× 112 0.7× 53 0.4× 133 1.2× 47 0.6× 30 551
Fanhua Kong China 16 445 1.8× 70 0.4× 255 2.0× 85 0.8× 45 0.5× 40 786
Roxana U. Miranda Mexico 12 201 0.8× 47 0.3× 57 0.5× 115 1.0× 60 0.7× 14 471

Countries citing papers authored by Yang Ke

Since Specialization
Citations

This map shows the geographic impact of Yang Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Ke more than expected).

Fields of papers citing papers by Yang Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Ke. The network helps show where Yang Ke may publish in the future.

Co-authorship network of co-authors of Yang Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Ke. A scholar is included among the top collaborators of Yang Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Ke. Yang Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Zisheng, et al.. (2025). Tumor Compression of the Hepatic or Portal Vein Predicts the Presence of Microvascular Invasion and Satellite Nodules in Hepatocellular Carcinoma: A Retrospective Study. Journal of Hepatocellular Carcinoma. Volume 12. 2055–2067. 2 indexed citations
3.
Ke, Yang, et al.. (2025). Li's bowknot technique: A modified Pringle maneuver for laparoscopic hepatectomy. Asian Journal of Surgery. 48(11). 7223–7224. 1 indexed citations
4.
5.
6.
7.
Ke, Yang, et al.. (2021). Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma. Molecular Therapy — Oncolytics. 23. 420–431. 16 indexed citations
8.
Xiang, Kui, Yan Wang, Cheng Zhang, et al.. (2021). Prognostic value of SH3PXD2B (Tks4) in human hepatocellular carcinoma: a combined multi-omics and experimental study. BMC Medical Genomics. 14(1). 115–115. 7 indexed citations
9.
Yang, Ye, Tingting Guo, Jun‐Wei Xu, et al.. (2021). Micelle nanovehicles for co-delivery of Lepidium meyenii Walp. (maca) polysaccharide and chloroquine to tumor-associated macrophages for synergistic cancer immunotherapy. International Journal of Biological Macromolecules. 189. 577–589. 28 indexed citations
10.
Zhang, Cheng, Yang Ke, Xin Liu, et al.. (2020). High Expression of the Long Noncoding RNA SNHG15 in Cancer Tissue Samples Predicts an Unfavorable Prognosis of Cancer Patients: A Meta-Analysis. Journal of Oncology. 2020. 1–14. 10 indexed citations
11.
12.
Bao, Tianhao, Yang Ke, Yifan Wang, et al.. (2018). Taraxasterol suppresses the growth of human liver cancer by upregulating Hint1 expression. Journal of Molecular Medicine. 96(7). 661–672. 50 indexed citations
13.
Ke, Yang, Tianhao Bao, Haoran Tang, et al.. (2018). Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study. World Journal of Clinical Cases. 6(5). 74–83. 11 indexed citations
14.
Ke, Yang, Tianhao Bao, Qi‐Xin Zhou, et al.. (2017). Discs large homolog 5 decreases formation and function of invadopodia in human hepatocellular carcinoma via Girdin and Tks5. International Journal of Cancer. 141(2). 364–376. 31 indexed citations
15.
Ke, Yang, Tianhao Bao, Xuesong Wu, et al.. (2016). Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activity. Biochemical and Biophysical Research Communications. 483(1). 509–515. 61 indexed citations
16.
Zhong, Jian‐Hong, Yang Ke, Shao‐Liang Zhu, et al.. (2016). Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection. OncoTargets and Therapy. Volume 9. 6897–6907. 10 indexed citations
17.
Wu, Xuesong, et al.. (2015). Hint1 Up-Regulates IκBα by Targeting the β-TrCP Subunit of SCF E3 Ligase in Human Hepatocellular Carcinoma Cells. Digestive Diseases and Sciences. 61(3). 785–794. 8 indexed citations
18.
Zhu, Shao‐Liang, Jian‐Hong Zhong, Yang Ke, et al.. (2015). Comparative efficacy of postoperative transarterial chemoembolization with or without antiviral therapy for hepatitis B virus-related hepatocellular carcinoma. Tumor Biology. 36(8). 6277–6284. 13 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chung-Kwe Wang Breakdown of academic impact, for papers by Maria Rita Emma Breakdown of academic impact, for papers by Xiong Cai Breakdown of academic impact, for papers by Huibin Lu Breakdown of academic impact, for papers by Yajing Yang Breakdown of academic impact, for papers by Weiya Cao Breakdown of academic impact, for papers by Hongyao Liu Breakdown of academic impact, for papers by Fanhua Kong Breakdown of academic impact, for papers by Roxana U. Miranda
Rankless by CCL
2026